CARL ZEISS MEDITEC ADR 1 Financial Flexibility Index
CARL ZEISS MEDITEC ADR 1 financial flexibility index. CARL ZEISS MEDITEC ADR 1 (AFXA) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of €144.16 Million (operating CF €144.16 Million minus capex €0.00) represents 0% of total liabilities (€1.28 Billion). Explore CARL ZEISS MEDITEC ADR 1 (AFXA) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of CARL ZEISS MEDITEC ADR 1 (2022–2025)
Financial flexibility index of CARL ZEISS MEDITEC ADR 1 from 2022 to 2025. Historical Financial Flexibility Index trend for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. Check CARL ZEISS MEDITEC ADR 1 total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CARL ZEISS MEDITEC ADR 1 Financial Flexibility Index by Year (2022–2025)
CARL ZEISS MEDITEC ADR 1 financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for CARL ZEISS MEDITEC ADR 1. For the full cash flow conversion analysis, see CARL ZEISS MEDITEC ADR 1 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | €286.45 Million | €209.86 Million | €1.28 Billion | ▼ -24.9% |
| 2024 | 0.30x | €399.52 Million | €247.32 Million | €1.34 Billion | ▼ -29.5% |
| 2023 | 0.42x | €364.72 Million | €250.86 Million | €860.02 Million | ▲ +24.4% |
| 2022 | 0.34x | €270.17 Million | €188.20 Million | €792.73 Million | — |